Literature DB >> 5002304

Chemical and biological properties of rifampicin.

S Furesz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5002304     DOI: 10.1159/000386837

Source DB:  PubMed          Journal:  Antibiot Chemother


× No keyword cloud information.
  14 in total

1.  Vertebral osteomyelitis and meningitis due to a penicillin-resistant pneumococcal strain.

Authors:  K Chemlal; J L Trouillet; C Carbon; P Yeni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

2.  Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients.

Authors:  Roger K Verbeeck; Bonifasius S Singu; Dan Kibuule
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

3.  A physiologically based pharmacokinetic model of rifampin in mice.

Authors:  Michael A Lyons; Brad Reisfeld; Raymond S H Yang; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

4.  Intraocular penetration of rifampin after oral administration.

Authors:  K W Wong; D J D'Amico; B S Oum; P A Baker; K R Kenyon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  Bone and joint tuberculosis: phthisis changes course.

Authors:  D J Gawkrodger; R B Cole
Journal:  Postgrad Med J       Date:  1982-12       Impact factor: 2.401

Review 7.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 8.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 9.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

10.  Effect of pyridoxine on rifampicin toxicity.

Authors:  Y P Yun; K H Kim; H S Kim; J H Chung
Journal:  Arch Pharm Res       Date:  1991-03       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.